Lawyers in the pharmaceutical and biotechnology industries have had their hands full fighting challenges to patents and accusations of price gouging. But it appears they are armed and ready to continue their fight, according to a global IP data survey of those industries.
A large percentage of chief IP counsel have seen an increase in their department budget and a sizable increase in staff over the past year, according to the survey, conducted by executive event organizer Consero Group. In fact, 68 percent believe they have enough resources to manage their department.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
